A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

August 31, 2023

Primary Completion Date

November 29, 2024

Study Completion Date

May 30, 2025

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Rosnilimab

PD-1 agonist antibody

DRUG

Placebo

Placebo

Trial Locations (92)

128

AnaptysBio Investigative Site 20-108, Roma

1023

AnaptysBio Investigative Site 28-101, Budapest

1036

AnaptysBio Investigative Site 28-104, Budapest

Anaptys Bio Investigative Site 28-106, Budapest

1070

AnaptysBio Investigative Site 13-102, Anderlecht

2170

AnaptysBio Investigative Site 13-103, Antwerp

3000

AnaptysBio Investigative Site 13-104, Leuven

4000

AnaptysBio Investigative Site 13- 105, Liège

4011

AnaptysBio Investigative Site 67-101, Košice

4032

AnaptysBio Investigative Site 28-103, Debrecen

10117

AnaptysBio Investigative Site 71-102, Tallinn

12161

AnaptysBio Investigative Site 17-103, Berlin

13419

AnaptysBio Investigative Site 71-101, Tallinn

14004

AnaptysBio Investigative Site 24-105, Córdoba

15702

AnaptysBio Investigative Site 24-104, Santiago de Compostela

15706

AnaptysBio Investigative Site 24-103, Santiago de Compostela

15895

AnaptysBio Investigative Site 24-102, Santiago de Compostela

20095

AnaptysBio Investigative Site 17-102, Hamburg

20122

AnaptysBio Investigative Site 20-110, Milan

20162

AnaptysBio Investigative Site 20-106, Milan

25801

AnaptysBio Investigative Site 10-117, Beckley

27100

AnaptysBio Investigative Site 20-101, Pavia

27577

AnaptysBio Investigative Site 10-148, Smithfield

28100

AnaptysBio Investigative Site 20-105, Novara

30159

AnaptysBio Investigative Site 17-107, Hanover

31059

AnaptysBio Investigative Site 16-102, Toulouse

32117

AnaptysBio Investigative Site 10-125, Daytona Beach

33032

AnaptysBio Investigative Site 10-122, Homestead

33125

Anaptys Bio Investigative Site 10-142, Miami

33126

AnaptysBio Investigative Site 10-140, Miami

33155

AnaptysBio Investigative Site 10-102, Miami

33180

AnaptysBio Investigative Site 10-103, Aventura

33324

AnaptysBio Investigative Site 10-124, Plantation

33407

AnaptysBio Investigative Site 10-139, West Palm Beach

33436

AnaptysBio Investigative Site 10-118, Boynton Beach

33825

AnaptysBio Investigative Site 10-141, Avon Park

34090

AnaptysBio Investigative Site 16-101, Montpellier

38305

AnaptysBio Investigative Site 10-101, Jackson

44130

AnaptysBio Investigative Site 10-146, Middleburg Heights

44649

AnaptysBio Investigative Site 17-105, Herne

46000

AnaptysBio Investigative Site 16-105, Cahors

48013

AnaptysBio Investigative Site 24-101, Bilbao

50106

AnaptysBio Investigative Site 71-103, Tartu

60640

AnaptysBio Investigative Site 10-114, Chicago

60693

AnaptysBio Investigative Site 30-112, Poznan

70124

AnaptysBio Investigative Site 20-104, Bari

71203

AnaptysBio Investigative Site 10-145, Monroe

75013

AnaptysBio Investigative Site 10-120, Allen

75024

AnaptysBio Investigative Site 10-110, Plano

75150

AnaptysBio Investigative Site 10-108, Mesquite

76034

AnaptysBio Investigative Site 10-107, Colleyville

77375

AnaptysBio Investigative Site 10-121, Tomball

77382

AnaptysBio Investigative Site 10-106, The Woodlands

77450

AnaptysBio Investigative Site 10-123, Katy

85037

AnaptysBio Investigative Site 10-129, Phoenix

85306

AnaptysBio Investigative Site 10-130, Glendale

85704

AnaptysBio Investigative Site 10-131, Tucson

86001

AnaptysBio Investigative Site 10-132, Flagstaff

87102

AnaptysBio Investigative Site 10-116, Albuquerque

90602

AnaptysBio Investigative Site 10-112, Whitter

91722

AnaptysBio Investigative Site 10-105, Covina

91786

AnaptysBio Investigative Site 10-133, Upland

92101

AnaptysBio Investigative Site 67-103, Piešťany

92108

AnaptysBio Investigative Site 10-113, San Diego

92270

Anaptys Bio Investigative Site 10-119, Rancho Mirage

92592

AnaptysBio Investigative Site 10-136, Temecula

94123

AnaptysBio Investigative Site 10-127, San Francisco

02445

AnaptysBio Investigative Site 10-143, Brookline

L2E6A6

AnaptysBio Investigative Site 11-104, Niagara Falls

N8X1T3

AnaptysBio Investigative Site 11-101, Windsor

G9A 3Y2

AnaptysBio Investigative Site 11-103, Trois-Rivières

0112

AnaptysBio Investigative Site 59-101, Tbilisi

0131

AnaptysBio Investigative Site 59-105, Tbilisi

0159

AnaptysBio Investigative Site 59-104, Tbilisi

AnaptysBio Investigative Site 59-106, Tbilisi

0160

AnaptysBio Investigative Site 59-102, Tbilisi

0172

AnaptysBio Investigative Site 59-103, Tbilisi

MD-2025

AnaptysBio Investigative Site73-101, Chisinau

61-113

AnaptysBio Investigative Site 30-105, Poznan

61-293

AnaptysBio Investigative Site 30-101, Poznan

87-100

AnaptysBio Investigative Site 30-104, Torun

67-100

AnaptysBio Investigative Site 30-103, Nowa Sól

02-118

AnaptysBio Investigative Site 30-107, Warsaw

45-819

AnaptysBio Investigative Site 30-106, Opole

41-902

AnaptysBio Investigative Site 30-102, Bytom

15-707

AnaptysBio Investigative Site 30-111, Bialystok

85-065

AnaptysBio Investigative Site 30-109, Bydgoszcz

00-874

AnaptysBio Investigative Site 30-108, Warsaw

03601

AnaptysBio Investigative Site 67-102, Martin

01135

AnaptysBio Investigative Site 34-101, Kyiv

IG14HP

AnaptysBio Investigative Site 27-101, London

M278FF

AnaptysBio Investigative Site 27-102, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AnaptysBio, Inc.

INDUSTRY

NCT06041269 - A Study of Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis (RENOIR) | Biotech Hunter | Biotech Hunter